Nature Medicine Features KineMed, Inc.'s Fibrosis Research, Which Aims to Advance Therapeutics for the Underlying Cause of 45% of All Deaths
(BUSINESS WIRE)--KineMed Inc.’s (www.kinemed.com) fibrosis research program, which aims to advance the discovery and development of drugs to treat this major disease, is featured in the January edition of Nature Medicine.